NCT04401345View on ClinicalTrials.gov

Effect of Glycopyrrolate on Vasopressors Requirement for Non-elective Caesarean Section Under Spinal Anaesthesia

PHASE4CompletedINTERVENTIONAL

Enrollment

258

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions

GlycopyrrolatePost-spinal HypotensionEffect of DrugHemodynamic Instability

Interventions

DRUG

Glycopyrrolate 0.2 MG/ML

In this group, the patients will receive glycopyrrolate 0.2 mg in 1 ml

DRUG

Normal saline

In this group, the patients will receive 1 ml of 0.9% normal saline

Trial Locations (1)

56700

B.P.Koirala Institute of Health Sciences, Dharān

All Listed Sponsors

lead

Rajesh Deshar

OTHER

NCT04401345 - Effect of Glycopyrrolate on Vasopressors Requirement for Non-elective Caesarean Section Under Spinal Anaesthesia | Biotech Hunter | Biotech Hunter